2024    2023    2022    2021    2020    2019    2018    2017    2016   

2020

Articles

111 - 

Inter-observer reliability of a 4-item Doppler ultrasound waveforms classification

Damien Lanéelle, Robert Scissons, Guillaume Mahé

VASA, 2020, 49 (6), pp.518-519.

DOI : https://doi.org/10.1024/0301-1526/a000906

Pubmed : 33103624

 

112 - 

Kidney transplantation improves the clinical outcomes of Acute Intermittent Porphyria

Hélène Lazareth, Neila Talbi, Nassim Kamar, Charlène Levi, Bruno Moulin et al.

Molecular Genetics and Metabolism, 2020, 131 (1-2), pp.259-266.

DOI : https://doi.org/10.1016/j.ymgme.2020.08.004

Pubmed : 32893121

 

113 - 

VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate Study

Catherine Le Berre, Mathurin Flamant, Guillaume Bouguen, Laurent Siproudhis, Marie Dewitte et al.

Journal of Crohn's and Colitis, 2020, 14 (11), pp.1512-1523.

DOI : https://doi.org/10.1093/ecco-jcc/jjaa100

Pubmed : 32417910

 

114 - 

Modification de la perception des sons sous antiépileptiques : une revue de la littérature et des bases de pharmacovigilance Pitch perception modification due to antiepileptics: A literature and pharmacovigilance databases review

B. Le Daré, L. Triquet, A. Degremont, H. Charbonnel, A. Default et al.

Modification de la perception des sons sous antiépileptiques : une revue de la littérature et des bases de pharmacovigilance. Therapies, 2020, 75 (6), pp.599-604.

DOI : https://doi.org/10.1016/j.therap.2020.02.017

Pubmed : 32204934

 

115 - 

Long-term outcome of patients with non-operated prosthetic valve infective endocarditis is relapse the main issue?

Raphaël Lecomte, Jean-Baptiste Laine, Nahéma Issa, Matthieu Revest, Benjamin Gaborit et al.

Clinical Infectious Diseases, 2020, 71 (5), pp.1316-1319.

DOI : https://doi.org/10.1093/cid/ciz1177

Pubmed : 31858123

 

116 - 

Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score

Mathilde Lefort, Yohann Foucher, Rémi Lenain, Sandra Vukusic, Gilles Edan et al.

Pharmacoepidemiology and Drug Safety, 2020, 29 (12), pp.1680-1688.

DOI : https://doi.org/10.1002/pds.5154

Pubmed : 33078476

 

117 - 

Enteric Nervous System Remodeling in a Rat Model of Spinal Cord Injury: A Pilot Study

Chloë Lefèvre, Anne Bessard, Philippe Aubert, Charles Joussain, François Giuliano et al.

Neurotrauma Reports, 2020, 1 (1), pp.125-136.

DOI : https://doi.org/10.1089/neur.2020.0041

Pubmed : 34223537

 

118 - 

The endogenous capacity to produce proinflammatory mediators by the ex vivo human perfused lung

Aleksandra Leligdowicz, James T Ross, Nicolas Nesseler, Michael A Matthay

Intensive Care Medicine Experimental, 2020, 8 (1), pp.56.

DOI : https://doi.org/10.1186/s40635-020-00343-x

Pubmed : 32955627

 

119 - 

Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function

Florian Lemaitre, Camille Tron, Thomas Renard, Caroline Jezequel, Pauline Houssel-Debry et al.

Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function. Therapeutic Drug Monitoring, 2020, 42 (5), pp.671-678.

DOI : https://doi.org/10.1097/FTD.0000000000000779

Pubmed : 33186335

 

120 - 

Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments

Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens et al.

Fundamental & Clinical Pharmacology, 2020, 34 (5), pp.530-547.

DOI : https://doi.org/10.1111/fcp.12586

Pubmed : 32603486